Morphine Adverse Reaction Terminated Phase 4 Trials for Morphine (DB00295)

IndicationStatusPhase
DBCOND0043635 (Morphine Adverse Reaction)Terminated4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01844206Two Dose Epidural Morphine for Post-cesarean AnalgesiaTreatment